Introduction
Steroid hormone receptors and related proteins represent a unique class of transcription factors that directly regulate gene expression in response to small hydrophobic ligands. Members of this superfamily of intracellular receptors generally share a common domain organization, consisting of a zinc-finger DNA-binding domain flanked by a C-terminal ligand-binding domain and an Nterminal domain of diverse length and sequence. Recent years have seen considerable progress in our understanding of how these receptors recog-nize and bind specific DNA-response elements, while the crystal structures of the isolated ligandbinding domains of both steroid and non-steroid members of the family, in the absence of ligand or with bound agonist or antagonist, has helped to formulate working models for the role of ligand in regulating receptor function ([l], and Pike et al., this issue, pp. 396400). Increasingly, attention is now being focused on investigating how these ligand-activated transcription factors regulate gene expression. A major breakthrough has been the identification of a diverse range of proteins that interact with nuclear receptors in either the absence or the presence of specific ligands ([2,3], see also Janne et al., this issue, pp. 401-4051. Of particular interest has been the realization that some of these proteins, either alone or as part of multi-subunit complexes, harbour enzymic activity, most notably histone acetyltransferase, deactylase, methyltransferase or kinase activities.
Chromatin
DNA in eukaryotic cells is compressed and packaged with histone and non-histone proteins. The fundamental unit of chromatin is the nucleosome particle, which gives rise to the classic image of ' beads on a string ' . The nucleosome core particle consists of approx. 146 bp of DNA wrapped in 1.65 turns around an octamer of the core histones: two each of H2A, H2B, H3 and H4 
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mosomal DNA into chromatin represents a significant barrier to a number of nuclear processes such as transcription, DNA repair and replication, it is necessary that cells have evolved strategies that permit the remodelling of local chromatin structure and access to the DNA substrate. The key in recent years has been not to think of chromatin as a static structure, with the DNA locked away, but rather as a dynamic structure. The fluidity of chromatin involves multiprotein complexes that have been described in a range of organisms from the budding yeast Saccharomyces cerevisiae to humans. These complexes exhibit one of two mechanisms of action, involving either the hydrolysis of ATP to alter histoneDNA interactions (reviewed in [6] ) or the covalent modification of histone tails to disrupt higher-order and/or nucleosome structures (reviewed in [7, 8] ).
Nuclear receptors and chromatin remodelling SWI-SNF complex
Genetic studies in the budding yeast S. cerevisiae led initially to the identification of components of the SWI-SNF complex as positive regulators of the HO and SUC2 genes, involved in mating type switching and sucrose fermentation respectively [6] . It was subsequently found that mutations in S WI-SNF genes had pleiotropic effects on transcription and that suppressors of these mutations mapped to histone and HMG-related genes, indicating a role in chromatin structure. Homologues of the yeast SWI-SNF complex have subsequently been identified in metazoans, for example the Brahma complex in Drosophila and the hBRM and BRG-1 complexes in human cells [6] . These complexes have a number of subunits in common, including a protein with a helicase-like domain: SWI2/SNF2 (yeast), Brahma (Drosophila), hBRM and BRG-1 (human). The SWI-S N F complex is thought to use the energy from ATP hydrolysis to alter histoneDNA interactions and lead to displacement or disruption of the nucleosome (see Whitehouse et al., this issue, pp. 376-379). More recently, other ATPhydrolysing complexes have been described, although these are less well characterized ; they include N U R F (nucleosome remodelling factor), CHRAC (chromatin accessibility complex), ACF (ATP-dependent chromatin assembly and remodelling factor) and RSF (remodelling and spacing factor) (reviewed in [6] ). These four complexes share a common ATPase subunit termed ISWI (imitation of switch) or hSNF2H.
A role for the SWI-SNF complex in steroid receptor action was first demonstrated by Yamamoto and colleagues with a yeast model system [9] . Mutations in the S W I l , SWI2/SNF2 or SWI3 genes disrupted glucocorticoid receptor (GR) function, while SW13 protein could be co-immunoprecipitated with G R derivatives containing the DNA-binding domain (DBD). Subsequent work in several laboratories has shown a role for the Drosophila Brahma and human BRG-1 gene products in transcriptional activation by GR, oestrogen receptor (ER) and retinoic acid receptor (RAR) [10, 11] , as well as the binding of GR and progesterone receptor to BRG-1 [12, 13] . More re-Steroid Receptor Co-Activators and Chromatin Remodelling cently, G R has been shown to recruit the SWI-S N F complex to chromatin templates in both yeast and mammalian cells and in cell-free systems [14, 15] . Mutations that impair the function of the G R N-terminal transactivation domain (termed r l ) also disrupt interactions with the SWI-SNF complex [ 1 51.
Covalent modification of histones Acetylation
The tails of the core histones are known to be covalently modified by phosphorylation, acetylation, methylation, ubiquitination and ADPribosylation (reviewed in [8] ). The association of histone acteylation with active gene expression has been well documented, but what was not clear was how this modification could be targeted to specific genes. An important breakthrough came with the identification of a histone acetyltransferase (HAT) enzyme from Tetrahymena as the homologue of a known yeast co-activator protein Gcn5 [16] . Gcn5 is present in two multiprotein complexes termed Ada (alteration/deficiency in activation) and SAGA (Spt-Ada-GcnS-acetyltransferase), reflecting the distinct nature of the subunits present (reviewed in [17] ).
The involvement of the Ada-Gcn5-containing complexes and G R transactivation was again initially demonstrated by using yeast genetics. In an ada2, ada3 or gcn5 gene deletion background the activity of G R was significantly compromised and this phenotype mapped to the N-terminal transactivation domain of the receptor [18] . Further studies by Wright and colleagues revealed that G R activity on chromatin templates was dependent specifically on the GcnS H A T activity in the context of the SAGA complex ([ 191 ; see also Wallberg et al., this issue, pp. 410414). In independent studies, the Ada3 protein was identified binding to the retinoid-x receptor (RXR) and ER ligand-binding domains in a ligand-dependent manner in a yeast two-hybrid assay [20] . Deletion of the ada2, ada3 or gcn5 genes impaired transactivation by a derivative of the ER. Strikingly, the overexpression of Ada3 suppressed the mutations in the ada2 andgcn5 genes but not vice versa, suggesting that Ada3 might act independently of Ada2 and GcnS [20] . The nature of the Ada-Gcn5 complex(es) involved remains to be determined, as does whether the Gcn5 HAT activity is required for ER function in this system. Several proteins that have been identified as co-activators for members of the nuclear receptor superfamily have also been found to possess HAT activity, including p3OO/CBP (CREB-binding protein), the mammalian homologue of yeast Gcn5, p/CAF (pSOO/CBP-associated factor) and members of the steroid receptor co-activator pl60 family of proteins (reviewed in [2, 3] ). In an elegant series of experiments, Kraus and Kadonaga [21] have shown that the ability of p300 to enhance ER-dependent transactivation in a cellfree transcription assay was dependent on chromatin templates; no stimulation was observed with naked DNA. It will be interesting to see whether p300 H A T activity or the ability to interact with P/CAF is required for this co-activation.
Methylation
The recent discovery of a protein called CARMl (co-activator-associated arginine methyltransferase 1) interacting with members of the p160 family of nuclear receptor co-activators has highlighted a possible role for histone methylation in nuclear receptor action [22] . Intriguingly, CARMl interacts with the very C-terminal region of GRIPl/TIF2, which is distinct from the CBP and receptor interacting surfaces. In transient transfection studies with a number of nuclear receptors, a clear synergism is observed when both GRIPl/TIF2 and CARMl are present. CARMl was found to be specific for histone H3 in vitro; however, it remains to be formally demonstrated whether histones in the context of nucleosomes are targeted by this enzyme and whether the methyltransferase activity is required for nuclear receptor action (see Stallcup et al., this issue, pp. 41 5-41 8).
Co-repressors
Non-steroid receptors, such as the thyroid hormone receptor and retinoic acid receptor, bind to response elements as heterodimers with RXR; in the absence of ligand they repress transcription from target genes. Expression cloning studies have identified co-repressor proteins, for example NCoR (nuclear receptor co-repressor) and S M R T (silencing mediator for retinoid and thyroid receptors), which bind these receptors in the absence of ligand ( [2, 3] , and references therein). Recent studies have characterized two receptor-interacting domains within NCoR and SMRT, containing the core motif LxxI/HxxxI/L that is predicted to form an amphipathic a-helix (see Love et al., this issue, pp. 390-396). This sequence is reminiscent of the LxxLL motif found in a number of co-activator proteins, and suggested that these co-repressors would bind a surface on the receptor overlapping with the co-activator binding site. A combination of molecular modelling and compe-tition experiments support this model (Love et al., pp. 390-396, and references therein).
Investigation of the possible mechanism of repression by NCoR and SMRT has revealed that these co-repressors are present in multi-subunit complexes with a protein called Sin3A and a histone deacetylase , HDACl [2,3] , thus correlating gene repression by nuclear receptors with the recruitment of a co-repressor complex with histone deacetylase activity and chromatin assembly (see Wolffe et al., this issue, pp. 379-385, and Lutz et al., this issue, pp. 386-389, for a further discussion of repression mechanisms).
Conclusions
The mouse mammary tumour virus long terminal repeat (MMTV-LTR) has long been favoured as a model promoter for investigating the mechanism of action of steroid receptors. Hager and coworkers established that this DNA incorporates six positioned nucleosomes (reviewed in [2] ). The laboratories of Wrange, Beato and Hager have further shown that although this structure impedes the binding of some transcription factors (NF-1 and OCT-l), GR is capable of binding to its cognate response element within the nucleosomes ( [2] , and references therein). Taken together, the results suggest a model in which GR bound to DNA results in the disruption of the local chromatin structure, which then allows access to NF-1, OCT-1 and the general transcription machinery (Figure 2) . The identification of chromatin remodelling complexes, described above, clearly provides plausible mechanisms for the nuclear receptor-dependent disruption of chromatin on the MMTV-LTR and other target gene promoters (Figure 2 ) (see also Hager et al., this issue, pp. 405-410). With regard to chromatin remodelling and nuclear receptor action a number of questions remain, for example :
1. What are the molecular details of the mechanism of action of chromatin remodelling complexes? Is it sufficient to 'move' key nucleosomes or is it necessary to displace or disrupt the entire histoneDNA complex ? 2. Why are there so many remodelling complexes? Are they redundant or can we expect receptor/promoter specific interactions ?
3. Do all proteins with HAT activity acetylate histones ? Answers to some of these questions are already beginning to emerge and we can expect further developments in this fast-moving field in the not too distant future. What is clear from the above studies and the recent two-day colloquium, held in Leeds as part of the Biochemical Society's annual meeting, is that the dynamic nature of chromatin and its role in regulating nuclear processes are now on centre stage.
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particle is essentially symmetrical in the vicinity of the dyad, the linker histone binds asymmetrically in this region to select a single high-affinity site from potentially two equivalent sites. T o try to resolve this apparent paradox we mapped to basepair resolution the dyads and rotational settings of nucleosome core particles reassembled on syn-
